NP92619 ERT Medicines
A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- 4 year
- Value
- £10M
- Sector
- HEALTH
- Published
- 18 Jul 2023
- Delivery
- 01 Oct 2019 to 30 Sep 2023
- Deadline
- n/a
Related Terms
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Takeda Bucks
Description
Total Quantity or Scope
The following Framework Agreements have been extended and are for the supply of the following ERT Medicines to NHS Scotland: NP92619 (e) - Velaglucerase alfa - VPRIV®, NP92619 (f) - Idursulfase - Elaprase®, NP92619 (g) - Agalsidase Alfa - Replagal®.
Award Detail
| 1 | Takeda (Bucks)
|
CPV Codes
- 33600000 - Pharmaceutical products
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated values of the Framework Agreements referred to in Section V.2.4 covers the twenty one (21) month contract duration and the twenty seven (27) month extension period of the Framework Agreement. OJEU notice numbers for each of the individual Awards: NP92619 (e)VPRIV®- 2019/S 170-415138 NP92619 (f)Elaprase®- 2019/S 170-415129 NP92619 (g)Replagal®- 2019/S 170-415117 (SC Ref:737956)
Reference
- ocds-h6vhtk-03e2c3
- FTS 020565-2023